Difference between revisions of "Profile drafts"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
| + | |||
| + | Short Title: QIBA DRAFT Profile: SPECT dopamine transporters | ||
*[[Media:001.QIBA_SPECT_Profile.v0.1_BEZ_2016.02.16_pre-tcon-2_NOedits.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {with stats input - Dr. Obuchowski}]] ''February 16, 2016'' | *[[Media:001.QIBA_SPECT_Profile.v0.1_BEZ_2016.02.16_pre-tcon-2_NOedits.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {with stats input - Dr. Obuchowski}]] ''February 16, 2016'' | ||
| Line 4: | Line 6: | ||
*[[Media:001.QIBA_SPECT_Profile.v0.1_BEZ_2016.02.16_pre-tcon-2.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease {comments - Dr. Zimmerman}]] ''February 16, 2016'' | *[[Media:001.QIBA_SPECT_Profile.v0.1_BEZ_2016.02.16_pre-tcon-2.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease {comments - Dr. Zimmerman}]] ''February 16, 2016'' | ||
| − | *[[Media:001 QIBA_SPECT_Profile v0 1 JCD 2016 01 21.docx| QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease | + | *[[Media:001 QIBA_SPECT_Profile v0 1 JCD 2016 01 21.docx| QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease {Dr. Seibyl}]] ''January 22, 2016'' |
Revision as of 15:30, 18 February 2016
Short Title: QIBA DRAFT Profile: SPECT dopamine transporters
- QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {with stats input - Dr. Obuchowski} February 16, 2016